Erin George

1.3k total citations
25 papers, 526 citations indexed

About

Erin George is a scholar working on Oncology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Erin George has authored 25 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Molecular Biology and 6 papers in Obstetrics and Gynecology. Recurrent topics in Erin George's work include DNA Repair Mechanisms (9 papers), PARP inhibition in cancer therapy (9 papers) and CAR-T cell therapy research (5 papers). Erin George is often cited by papers focused on DNA Repair Mechanisms (9 papers), PARP inhibition in cancer therapy (9 papers) and CAR-T cell therapy research (5 papers). Erin George collaborates with scholars based in United States, United Kingdom and South Africa. Erin George's co-authors include Fiona Simpkins, Mark A. Morgan, Rugang Zhang, Ryan L. Ragland, Eric J. Brown, Hyoung Kim, Meenhard Herlyn, Stavros Rafail, Clemens Krepler and Thomas J. Herzog and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Erin George

22 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin George United States	9	326	312	117	70	63	25	526
Tasuku Mariya Japan	11	227 0.7×	257 0.8×	63 0.5×	109 1.6×	63 1.0×	47	536
Ivana Rizzuto United Kingdom	10	150 0.5×	141 0.5×	173 1.5×	38 0.5×	70 1.1×	24	457
Elisabet Sanchez United Kingdom	11	268 0.8×	190 0.6×	194 1.7×	67 1.0×	38 0.6×	19	512
Lucia Musacchio Italy	15	283 0.9×	151 0.5×	203 1.7×	93 1.3×	170 2.7×	46	551
Takuhei Yokoyama Japan	11	117 0.4×	174 0.6×	141 1.2×	39 0.6×	107 1.7×	17	399
Yuichi Imai Japan	10	109 0.3×	136 0.4×	52 0.4×	84 1.2×	37 0.6×	23	297
Sang Young Ryu South Korea	8	213 0.7×	82 0.3×	201 1.7×	33 0.5×	65 1.0×	18	349
Sho Sato Japan	12	157 0.5×	117 0.4×	132 1.1×	101 1.4×	116 1.8×	32	411
Luis Z. Blanco United States	11	165 0.5×	69 0.2×	86 0.7×	63 0.9×	60 1.0×	32	358
Kristen Bunch United States	8	101 0.3×	140 0.4×	94 0.8×	64 0.9×	38 0.6×	18	311

Countries citing papers authored by Erin George

Since Specialization

Citations

This map shows the geographic impact of Erin George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin George more than expected).

Fields of papers citing papers by Erin George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin George. The network helps show where Erin George may publish in the future.

Co-authorship network of co-authors of Erin George

This figure shows the co-authorship network connecting the top 25 collaborators of Erin George. A scholar is included among the top collaborators of Erin George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin George. Erin George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Haineng, Erin George, David Gallo, et al.. (2025). Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR. Nature Communications. 16(1). 3112–3112. 6 indexed citations

Nasioudis, Dimitrios, et al.. (2024). CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?. Diagnostics. 14(8). 819–819. 11 indexed citations

Nasioudis, Dimitrios, Erin George, & János L. Tanyi. (2023). Controversies in the Staging of Patients with Locally Advanced Cervical Cancer. Diagnostics. 13(10). 1747–1747.

Nasioudis, Dimitrios, Erin George, Haineng Xu, Hyoung Kim, & Fiona Simpkins. (2023). Combination DNA Damage Response (DDR) Inhibitors to Overcome Drug Resistance in Ovarian Cancer. Cancer treatment and research. 186. 189–206. 3 indexed citations

Gitto, Sarah B., Erin George, Sergey Medvedev, Fiona Simpkins, & Daniel J. Powell. (2021). Humanized Patient-Derived Xenograft Models of Ovarian Cancer. Methods in molecular biology. 2424. 255–274. 3 indexed citations

Pierini, Stefano, János L. Tanyi, Fiona Simpkins, et al.. (2020). Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight. 5(16). 19 indexed citations

Gilad, Oren, et al.. (2020). Synthetic-lethal interactions between ATR inhibition and functional genetic and proteomic biomarkers to predict responses in endometriosis-associated cancers.. Journal of Clinical Oncology. 38(15_suppl). e18000–e18000. 2 indexed citations

Pamarthy, Sahithi, Tina Gill, Erin George, et al.. (2019). Abstract 3498: Highly specific macrocyclic ATR inhibitors for the targeted treatment of a broad spectrum of cancers showing lack of anemia or neutropenia in pre-clinical animal models. 3498–3498. 1 indexed citations

George, Erin, et al.. (2018). Improving the efficacy of PARP inhibition with a novel ATR inhibitor, ATRN119, in ovarian high-grade serous cancers. Gynecologic Oncology. 149. 45–45. 3 indexed citations

10.

George, Erin, Ryan L. Ragland, Stavros Rafail, et al.. (2017). Targeting the ATR-Chk1 axis with PARP inhibition results in tumor regression in BRCA mutant models. Gynecologic Oncology. 145. 100–100. 3 indexed citations

11.

Kim, Hyoung, Erin George, Ryan L. Ragland, et al.. (2016). Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA -Mutant Ovarian Cancer Models. Clinical Cancer Research. 23(12). 3097–3108. 234 indexed citations

12.

Wang, Yifan, John J. Krais, Andrea J. Bernhardy, et al.. (2016). RING domain–deficient BRCA1 promotes PARP inhibitor and platinum resistance. Journal of Clinical Investigation. 126(8). 3145–3157. 79 indexed citations

13.

Butler, Laura, Ryan L. Ragland, Erin George, et al.. (2016). Abstract 1226: Highly specific ATR inhibitors as a therapeutic approach for a broad spectrum of cancers. Cancer Research. 76(14_Supplement). 1226–1226. 1 indexed citations

14.

George, Erin, Ana I. Tergas, Cande V. Ananth, et al.. (2014). Safety and Tolerance of Radical Hysterectomy for Cervical Cancer in the Elderly. Gynecologic Oncology. 134(1). 36–41. 19 indexed citations

15.

George, Erin, Thomas J. Herzog, Alfred I. Neugut, et al.. (2013). Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome. Gynecologic Oncology. 131(1). 42–45. 50 indexed citations

16.

Baxi, Laxmi & Erin George. (2013). Three-way tie. American Journal of Obstetrics and Gynecology. 209(6). 590.e1–590.e1. 1 indexed citations

17.

Horvath, Sarah, Erin George, & Thomas J. Herzog. (2013). Unintended Consequences: Surgical Complications in Gynecologic Cancer. Women s Health. 9(6). 595–604. 7 indexed citations

18.

Schulman‐Green, Dena, et al.. (2012). One Step at a Time: Self-Management and Transitions Among Women With Ovarian Cancer. Oncology nursing forum. 39(4). 354–360. 33 indexed citations

19.

George, Erin, Santos E. Cabreriza, T. Alexander Quinn, et al.. (2010). Validation of Automated Monitoring of Cardiac Output for Biventricular Pacing Optimization. ASAIO Journal. 56(3). 265–269. 2 indexed citations

20.

Nelson, Karen, Erin George, Christina D. Swenson, John W. Forstrom, & K E Hellström. (1987). Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.. The Journal of Immunology. 139(6). 2110–2117. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact